An in vitro study has demonstrated that T-Dxd could induce a potent “bystander killing” effect on cells in close proximity to targeted HER2-expressing tumor cells by transferring the released payload into the neighboring cells, regardless of their HER2 status [79]. This evidence concerns the gene ERBB2 and neoplasm.